Jianjun Wang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- Epigenetics and DNA Methylation
Papers in
-
- Extracellular vesicles in disease 17
- Circular RNAs in diseases 13
- RNA modifications and cancer 6
-
- MicroRNA in disease regulation 28
- Cancer-related molecular mechanisms research 21
- Co-authors
- Yongliang Yao (18 shared papers)Jian Wu (17 shared papers)Guangxin Li (11 shared papers)Zeyou Wang (6 shared papers)Qinghui Zhang (9 shared papers)Tao Gu (6 shared papers)Jianfeng Guo (1 shared paper)Donglei Liu (1 shared paper)
- Journals
- Frontiers in Immunology (4 papers)Biomedicine & Pharmacotherapy (4 papers)Frontiers in Oncology (3 papers)Cancer Biomarkers (2 papers)Cancer Science (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Jianjun Wang
86 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 891
- Molecular Biology 1.3k
- Immunology 249
- Microbiology 48
- Oncology 159
Countries citing papers authored by Jianjun Wang
This map shows the geographic impact of Jianjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Wang more than expected).
Fields of papers citing papers by Jianjun Wang
This network shows the impact of papers produced by Jianjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Wang. The network helps show where Jianjun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianjun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 147 | |
| 2 | 2017 | 139 | |
| 3 | 2015 | 86 | |
| 4 | 2018 | 72 | |
| 5 | 2016 | 63 | |
| 6 | 2015 | 59 | |
| 7 | MicroRNA-155 in exosomes secreted from helicobacter pylori infection macrophages immunomodulates inflammatory response. | 2016 | 58 |
| 8 | 2013 | 52 | |
| 9 | 2014 | 49 | |
| 10 | 2018 | 48 | |
| 11 | 2008 | 47 | |
| 12 | 2020 | 47 | |
| 13 | 2014 | 45 | |
| 14 | Identification and analysis of exosomes secreted from macrophages extracted by different methods. | 2015 | 44 |
| 15 | 2019 | 44 | |
| 16 | 2013 | 36 | |
| 17 | 2015 | 36 | |
| 18 | 2016 | 36 | |
| 19 | 2019 | 35 | |
| 20 | 2015 | 33 |
About Jianjun Wang
Jianjun Wang is a scholar working on Molecular Biology, Cancer Research, Immunology, Surgery and Epidemiology, having authored 90 papers that have together received 1.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (28 papers), Cancer-related molecular mechanisms research (21 papers), Extracellular vesicles in disease (17 papers), Circular RNAs in diseases (13 papers), Galectins and Cancer Biology (7 papers), RNA modifications and cancer (6 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Mycobacterium research and diagnosis (4 papers). The work is most often cited by research in Cancer Research (891 citations), Molecular Biology (1.3k citations), Immunology (249 citations), Microbiology (48 citations) and Oncology (159 citations). Jianjun Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yongliang Yao, Jian Wu, Guangxin Li, Zeyou Wang, Qinghui Zhang, Tao Gu, Jianfeng Guo, Donglei Liu, Quan Liu and Jiguang Zhang. Their work appears in journals such as Frontiers in Immunology, Biomedicine & Pharmacotherapy, Frontiers in Oncology, Cancer Biomarkers and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.